Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized single-blind trial of LEO 90100 foam vs calcipotriol + betamethasone ointment in Chinese adults with stable plaque psoriasis
CTR20223222Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcipotriol + betamethasone in psoriasis, sponsored by LEO Pharma. Started Dec 2022; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20223222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223222.